Jolita Mereckiene

Health Protection Surveillance Centre — Ireland

Medicine · Health Sciences

22h-index2.4kcitations42works10.42yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Respiratory viral infections research(18), Pneumonia and Respiratory Infections(17), Influenza Virus Research Studies(16), Vaccine Coverage and Hesitancy(11), Bacterial Infections and Vaccines(8)

Publications42 total

Investigation of an outbreak of novel hepatitis of unknown aetiology in children and adolescents, Ireland, 2021 to 2023
Eurosurveillance·2025· 1 citedOpen Access
Global impact of 10-and 13-valent pneumococcal conjugate vaccines on pneumococcal meningitis in all ages: The PSERENADE project
Lirias (KU Leuven)·2025Open Access
Global impact of 10- and 13-valent pneumococcal conjugate vaccines on pneumococcal meningitis in all ages: The PSERENADE project
Journal of Infection·2025· 5 citedOpen Access
Global impact of ten-valent and 13-valent pneumococcal conjugate vaccines on invasive pneumococcal disease in all ages (the PSERENADE project): a global surveillance analysis
The Lancet Infectious Diseases·2024· 43 citedOpen Access
Global Impact of 10- and 13-Valent Pneumococcal Conjugate Vaccines on Invasive Pneumococcal Disease in All Ages: The PSERENADE Project
SSRN Electronic Journal·2024· 3 citedOpen Access
The effectiveness of interventions to improve the seasonal influenza vaccination uptake among nurses: A systematic review
Journal of Infection Prevention·2023· 8 citedOpen Access
Invasive pneumococcal surveillance to assess the potential benefits of extended spectrum conjugate vaccines (PCV15/PCV20) in older adults
Epidemiology and Infection·2023· 4 citedOpen Access
Effectiveness of 10 and 13-valent pneumococcal conjugate vaccines against invasive pneumococcal disease in European children: SpIDnet observational multicentre study
Vaccine·2022· 109 citedOpen Access
Serotype Replacement after Introduction of 10-Valent and 13-Valent Pneumococcal Conjugate Vaccines in 10 Countries, Europe
Emerging infectious diseases·2021· 155 citedOpen Access
Changes in Invasive Pneumococcal Disease Caused by Streptococcus pneumoniae Serotype 1 Following Introduction of PCV10 and PCV13: Findings from the PSERENADE Project
Bern Open Repository and Information System (University of Bern)·2021Open Access
Using genomics to examine the persistence of Streptococcus pneumoniae serotype 19A in Ireland and the emergence of a sub-clade associated with vaccine failures
Vaccine·2021· 27 citedOpen Access
Changes in Invasive Pneumococcal Disease Caused by Streptococcus pneumoniae Serotype 1 following Introduction of PCV10 and PCV13: Findings from the PSERENADE Project
Microorganisms·2021· 23 citedOpen Access
Invasive Streptococcus pneumoniae Infections and Vaccine Failures in Children in Ireland From the Postvaccine Era From 2007 to 2018
The Pediatric Infectious Disease Journal·2019· 17 cited
Determinants of influenza and pertussis vaccine uptake in pregnant women in Ireland: A cross-sectional survey in 2017/18 influenza season
Vaccine·2019· 37 cited
Is It Time To Review The Vaccination Strategy To Protect Adults Against Invasive Pneumococcal Disease?
PubMed·2019· 4 cited
Effect of childhood pneumococcal conjugate vaccination on invasive disease in older adults of 10 European countries: implications for adult vaccination
Thorax·2018· 165 citedOpen Access
Effectiveness of the 23-valent pneumococcal polysaccharide vaccine against Invasive Pneumococcal Disease incidence in European adults aged 65 years and above: results of SpIDnet/I-MOVE+ multicentre study (2012-2016)
Strathprints: The University of Strathclyde institutional repository (University of Strathclyde)·2018
Seasonal influenza vaccination and antiviral use in EU/EEA Member States: overview of vaccine recommendations for 2017-2018 and vaccination coverage rates for 2015-2016 and 2016-2017 influenza seasons.
2018· 83 cited
How close are countries of the WHO European Region to achieving the goal of vaccinating 75% of key risk groups against influenza? Results from national surveys on seasonal influenza vaccination programmes, 2008/2009 to 2014/2015
Vaccine·2017· 251 citedOpen Access
Decrease in the Uptake of Seasonal Influenza Vaccine in Persons Aged 65 Years and Older In Ireland since the 2009 Influenza A (H1N1) Pdm09 Pandemic.
PubMed·2017· 1 cited
page 1 of 3Next →

Frequent Co-authors

Suzanne Cotter(22), D O’Flanagan(14), Brita Askeland Winje(12), D Lévy-Brühl(10), Palle Valentiner‐Branth(10), Mary Corcoran(10), Pilar Ciruela(9), Fortunato D’Ancona(8), Cristina Giambi(8), Shamez Ladhani(8), J. Pekka Nuorti(8), Marcela Guevara(8), Jana Kozáková(8), Carmen Muñoz‐Almagro(8), Jesús Castilla(8), Camelia Savulescu(8), Laura MacDonald(8), Paweł Stefanoff(7), Juan Carlos Sanz(7), Pier Luigi Lopalco(6)